非侵襲性神経刺激装置の世界市場レポート2025年

非侵襲的神経刺激装置の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.8％で30億6,000万米ドルに成長します。予測される成長は、高齢化人口の増加、ウェアラブル神経刺激装置の使用増加、ヘルスケア支出の増加、政府の好意的な取り組み、メンタルヘルスケアにおける広範な使用と関連付けることができます。主な新たな動向としては、低侵襲刺激技術への移行、ワイヤレス神経刺激装置の革新、遠隔医療プラットフォームとの統合の拡大、クローズドループシステムの開発、個別化神経刺激アプローチの重視の高まりなどが挙げられます。

神経疾患の有病率の増加は、今後非侵襲的神経刺激装置市場の成長を促進すると予想されます。神経疾患は、脳、脊髄、神経に影響を及ぼし、認知障害、運動障害、感覚障害などさまざまな症状を引き起こす病状です。加齢は神経細胞機能を徐々に損ない、脳の可塑性を低下させ、酸化ストレスを上昇させ、神経学的問題の発症と進行に寄与するからです。非侵襲的神経刺激装置は、神経反応を評価するために標的を絞った刺激を与えることで、神経障害の診断を支援します。非外科的でリアルタイムの評価方法を提供することで、診断精度を向上させ、臨床と在宅の両環境における患者ケアを強化します。例えば、2024年7月、英国の政府機関である国民保健サービス（National Health Service）は、2024年6月30日までに、記憶、思考、日常活動に影響を及ぼす進行性の脳疾患である認知症と診断された患者が48万7,432人であったと報告し、2024年5月31日と比較して3,155人の増加を示しました。このような神経疾患の増加は、非侵襲的神経刺激装置市場の成長に大きく寄与しています。

非侵襲的神経刺激装置市場で事業を展開する主要企業は、治療効果と患者の転帰を高めるために、個別化刺激プロトコルなどの先進製品の開発に注力しています。個別化刺激プロトコルとは、神経刺激設定を個人の特定の病状、神経反応、治療目標に合わせて調整することで、副作用を最小限に抑えながら治療効果を最大化するものです。例えば、フィンランドに本社を置く医療技術企業Sooma Medical社は、2023年10月、非侵襲的経頭蓋直流電流刺激（tDCS）を用いた在宅治療用に設計された、臨床医がモニターする遠隔脳刺激システムを発表しました。この革新的なソリューションにより、医療専門家が遠隔で治療セッションを監督することが可能となり、うつ病や慢性疼痛などの神経症状や精神疾患を抱える患者の治療へのアクセスや治療のアドヒアランスが向上します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の非侵襲性神経刺激装置：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の非侵襲性神経刺激装置市場：成長率分析
• 世界の非侵襲性神経刺激装置市場の実績：規模と成長, 2019-2024
• 世界の非侵襲性神経刺激装置市場の予測：規模と成長, 2024-2029, 2034F
• 世界の非侵襲性神経刺激装置：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の非侵襲性神経刺激装置市場刺激技術の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮的電気神経刺激（TENS）
• 経頭蓋磁気刺激（TMS）
• 電磁刺激（EMS）
• その他の種類の刺激技術
• 世界の非侵襲性神経刺激装置市場対象適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 神経疾患
• 精神障害
• その他の対象適応症
• 世界の非侵襲性神経刺激装置市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 在宅ケア設定
• 調査・学術機関
• 世界の非侵襲性神経刺激装置市場経皮的電気神経刺激（TENS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の経皮的電気神経刺激（TENS）
• 鍼治療のような経皮的電気神経刺激（TENS）
• 短時間強力経皮的電気神経刺激（TENS）
• バーストモード経皮的電気神経刺激（TENS）
• 世界の非侵襲性神経刺激装置市場経頭蓋磁気刺激（TMS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 反復経頭蓋磁気刺激（rTMS）
• 深部経頭蓋磁気刺激（dTMS）
• 単パルス経頭蓋磁気刺激
• ペアパルス経頭蓋磁気刺激
• 世界の非侵襲性神経刺激装置市場電磁刺激（EMS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機能的電磁刺激（EMS）
• 神経筋電磁刺激（EMS）
• 高周波電磁刺激（EMS）
• 低周波電磁刺激（EMS）
• 世界の非侵襲性神経刺激装置市場、その他のタイプの刺激技術のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経頭蓋直流電流刺激（TDCS）
• 迷走神経刺激
• 頭蓋電気療法刺激（CES）
• 末梢神経刺激（PNS）

第7章 地域別・国別分析

• 世界の非侵襲性神経刺激装置市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の非侵襲性神経刺激装置市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 非侵襲性神経刺激装置市場：競合情勢
• 非侵襲性神経刺激装置市場：企業プロファイル
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Alpha-Stim Overview, Products and Services, Strategy and Financial Analysis
  • Neurosoft Bioelectronics SA Overview, Products and Services, Strategy and Financial Analysis
  • Neuronetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • BrainsWay Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• eNeura Inc.
• MagVenture A/S
• Nexstim Plc
• Neuroelectrics Barcelona S.L.U.
• Cefaly Technology
• ElectroCore Inc.
• Brainbox India Private Limited
• Flow Neuroscience AB
• Fisher Wallace Laboratories Inc.
• Sooma Medical
• Aleva Neurotherapeutics SA
• NeuroSigma Inc.
• Mind Alive Inc.
• TheBrainDriver LLC
• Caputron Medical Products LLC.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 非侵襲性神経刺激装置市場2029：新たな機会を提供する国
• 非侵襲性神経刺激装置市場2029：新たな機会を提供するセグメント
• 非侵襲性神経刺激装置市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Non-invasive neurostimulation devices are advanced medical technologies developed to influence neural activity without the need for surgical procedures. These devices utilize external techniques such as electrical, magnetic, or ultrasonic stimulation to focus on particular regions of the nervous system. Their primary objective is to treat neurological and psychiatric disorders like chronic pain, depression, and epilepsy by modifying brain or nerve activity in a safe and efficient manner.

The primary categories of non-invasive neurostimulation devices include transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), electromagnetic stimulation (EMS), and others. TENS involves the use of low-voltage electrical pulses delivered through the skin using electrodes as a method for non-invasive pain relief. These devices are employed across a variety of clinical applications such as pain management, neurological and psychological disorders, among others. They serve different end users including hospitals and clinics, homecare settings, and academic or research institutions.

The non invasive neurostimulation devices market size has grown rapidly in recent years. It will grow from $1.67 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. This growth during the historic period can be credited to a rise in neurological disorder cases, increased awareness about neurostimulation therapies, heightened demand for non-invasive treatment methods, enhanced healthcare infrastructure, and a surge in neuromodulation-related research.

The non-invasive neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The forecasted growth can be linked to the rising aging population, increased use of wearable neurostimulation devices, growing healthcare spending, favorable government initiatives, and broader use in mental health care. Key emerging trends include a transition to minimally invasive stimulation techniques, innovations in wireless neurostimulation devices, greater integration with telehealth platforms, the development of closed-loop systems, and a growing emphasis on personalized neurostimulation approaches.

The increasing prevalence of neurological disorders is expected to propel the growth of the non-invasive neurostimulation devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms including cognitive, motor, and sensory impairments. The growing occurrence of these conditions is closely linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of neurological issues. Non-invasive neurostimulation devices assist in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They provide non-surgical, real-time evaluation methods, improving diagnostic accuracy and enhancing patient care in both clinical and home settings. For example, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients diagnosed with dementia-a progressive brain disorder affecting memory, thinking, and daily activities-by June 30, 2024, marking an increase of 3,155 cases compared to May 31, 2024. This rise in neurological disorders is thereby contributing significantly to the growth of the non-invasive neurostimulation devices market.

Major companies operating in the non-invasive neurostimulation devices market are focusing on developing advanced products such as personalized stimulation protocols to enhance treatment effectiveness and patient outcomes. Personalized stimulation protocols involve tailoring neurostimulation settings to an individual's specific medical condition, neural response, and treatment goals to maximize therapeutic benefits while minimizing side effects. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, introduced a remote clinician-monitored brain stimulation system designed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative solution enables healthcare professionals to supervise therapy sessions remotely, improving accessibility and treatment adherence for patients with neurological and mental health conditions like depression and chronic pain.

In December 2024, ElectroCore Inc., a US-based medical technology company, acquired NeuroMetrix Inc. for an undisclosed amount. This acquisition allowed ElectroCore to expand its portfolio in non-invasive neuromodulation by incorporating NeuroMetrix's Quell pain relief device and DPNCheck diagnostic tool, strengthening its position in the field of bioelectronic medicine. NeuroMetrix Inc. is a US-based neurotechnology company that specializes in non-invasive neurostimulation devices.

Major players in the non invasive neurostimulation devices market are Boston Scientific Corporation, Alpha-Stim, Neurosoft Bioelectronics SA, Neuronetics Inc., BrainsWay Ltd., eNeura Inc., MagVenture A/S, Nexstim Plc, Neuroelectrics Barcelona S.L.U., Cefaly Technology, ElectroCore Inc., Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc., Sooma Medical, Aleva Neurotherapeutics SA, NeuroSigma Inc., Mind Alive Inc., TheBrainDriver LLC, and Caputron Medical Products LLC.

North America was the largest region in the non invasive neurostimulation devices market in 2024. The regions covered in non-invasive neurostimulation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-invasive neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-invasive neurostimulation devices market consists of revenues earned by entities by providing services such as pain management therapy, cognitive enhancement programs, rehabilitation support, mental health treatment, and remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-invasive neurostimulation devices market also includes sales of transcranial magnetic stimulators (TMS), transcranial direct current stimulators (tDCS), vagus nerve stimulators (non-implantable), external trigeminal nerve stimulators (eTNS), and wearable neurostimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non Invasive Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non invasive neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non invasive neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non invasive neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Stimulation Technology: Transcutaneous Electrical Nerve Stimulation (TENS); Transcranial Magnetic Stimulation (TMS); Electromagnetic Stimulation (EMS); Other Types Of Stimulation Technologies
• 2) By Target Indication: Pain Management; Neurological Disorders; Psychological Disorder; Other Target Indications
• 3) By End User: Hospitals And Clinics; Homecare Settings; Research And Academic Institutes
• Subsegments:
• 1) By Transcutaneous Electrical Nerve Stimulation (TENS): Conventional Transcutaneous Electrical Nerve Stimulation (TENS); Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (TENS); Brief-Intense Transcutaneous Electrical Nerve Stimulation (TENS); Burst Mode Transcutaneous Electrical Nerve Stimulation (TENS)
• 2) By Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS); Deep Transcranial Magnetic Stimulation (dTMS); Single-Pulse Transcranial Magnetic Stimulation; Paired-Pulse Transcranial Magnetic Stimulation
• 3) By Electromagnetic Stimulation (EMS): Functional Electromagnetic Stimulation (EMS); Neuromuscular Electromagnetic Stimulation (EMS); High-Frequency Electromagnetic Stimulation (EMS); Low-Frequency Electromagnetic Stimulation (EMS)
• 4) By Other Types Of Stimulation Technology: Transcranial Direct Current Stimulation (tDCS); Vagus Nerve Stimulation; Cranial Electrotherapy Stimulation (CES); Peripheral Nerve Stimulation (PNS)
• Companies Mentioned: Boston Scientific Corporation; Alpha-Stim; Neurosoft Bioelectronics SA; Neuronetics Inc.; BrainsWay Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non Invasive Neurostimulation Devices Market Characteristics

3. Non Invasive Neurostimulation Devices Market Trends And Strategies

4. Non Invasive Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Non Invasive Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Non Invasive Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Non Invasive Neurostimulation Devices Market Growth Rate Analysis
• 5.4. Global Non Invasive Neurostimulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Non Invasive Neurostimulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Non Invasive Neurostimulation Devices Total Addressable Market (TAM)

6. Non Invasive Neurostimulation Devices Market Segmentation

• 6.1. Global Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Transcranial Magnetic Stimulation (TMS)
• Electromagnetic Stimulation (EMS)
• Other Types Of Stimulation Technologies
• 6.2. Global Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Neurological Disorders
• Psychological Disorder
• Other Target Indications
• 6.3. Global Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Homecare Settings
• Research And Academic Institutes
• 6.4. Global Non Invasive Neurostimulation Devices Market, Sub-Segmentation Of Transcutaneous Electrical Nerve Stimulation (TENS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Transcutaneous Electrical Nerve Stimulation (TENS)
• Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (TENS)
• Brief-Intense Transcutaneous Electrical Nerve Stimulation (TENS)
• Burst Mode Transcutaneous Electrical Nerve Stimulation (TENS)
• 6.5. Global Non Invasive Neurostimulation Devices Market, Sub-Segmentation Of Transcranial Magnetic Stimulation (TMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Repetitive Transcranial Magnetic Stimulation (rTMS)
• Deep Transcranial Magnetic Stimulation (dTMS)
• Single-Pulse Transcranial Magnetic Stimulation
• Paired-Pulse Transcranial Magnetic Stimulation
• 6.6. Global Non Invasive Neurostimulation Devices Market, Sub-Segmentation Of Electromagnetic Stimulation (EMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Functional Electromagnetic Stimulation (EMS)
• Neuromuscular Electromagnetic Stimulation (EMS)
• High-Frequency Electromagnetic Stimulation (EMS)
• Low-Frequency Electromagnetic Stimulation (EMS)
• 6.7. Global Non Invasive Neurostimulation Devices Market, Sub-Segmentation Of Other Types Of Stimulation Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcranial Direct Current Stimulation (TDCS)
• Vagus Nerve Stimulation
• Cranial Electrotherapy Stimulation (CES)
• Peripheral Nerve Stimulation (PNS)

7. Non Invasive Neurostimulation Devices Market Regional And Country Analysis

• 7.1. Global Non Invasive Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Non Invasive Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non Invasive Neurostimulation Devices Market

• 8.1. Asia-Pacific Non Invasive Neurostimulation Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non Invasive Neurostimulation Devices Market

• 9.1. China Non Invasive Neurostimulation Devices Market Overview
• 9.2. China Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non Invasive Neurostimulation Devices Market

• 10.1. India Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non Invasive Neurostimulation Devices Market

• 11.1. Japan Non Invasive Neurostimulation Devices Market Overview
• 11.2. Japan Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non Invasive Neurostimulation Devices Market

• 12.1. Australia Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non Invasive Neurostimulation Devices Market

• 13.1. Indonesia Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non Invasive Neurostimulation Devices Market

• 14.1. South Korea Non Invasive Neurostimulation Devices Market Overview
• 14.2. South Korea Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non Invasive Neurostimulation Devices Market

• 15.1. Western Europe Non Invasive Neurostimulation Devices Market Overview
• 15.2. Western Europe Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non Invasive Neurostimulation Devices Market

• 16.1. UK Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non Invasive Neurostimulation Devices Market

• 17.1. Germany Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non Invasive Neurostimulation Devices Market

• 18.1. France Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non Invasive Neurostimulation Devices Market

• 19.1. Italy Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non Invasive Neurostimulation Devices Market

• 20.1. Spain Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non Invasive Neurostimulation Devices Market

• 21.1. Eastern Europe Non Invasive Neurostimulation Devices Market Overview
• 21.2. Eastern Europe Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non Invasive Neurostimulation Devices Market

• 22.1. Russia Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non Invasive Neurostimulation Devices Market

• 23.1. North America Non Invasive Neurostimulation Devices Market Overview
• 23.2. North America Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non Invasive Neurostimulation Devices Market

• 24.1. USA Non Invasive Neurostimulation Devices Market Overview
• 24.2. USA Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non Invasive Neurostimulation Devices Market

• 25.1. Canada Non Invasive Neurostimulation Devices Market Overview
• 25.2. Canada Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non Invasive Neurostimulation Devices Market

• 26.1. South America Non Invasive Neurostimulation Devices Market Overview
• 26.2. South America Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non Invasive Neurostimulation Devices Market

• 27.1. Brazil Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non Invasive Neurostimulation Devices Market

• 28.1. Middle East Non Invasive Neurostimulation Devices Market Overview
• 28.2. Middle East Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non Invasive Neurostimulation Devices Market

• 29.1. Africa Non Invasive Neurostimulation Devices Market Overview
• 29.2. Africa Non Invasive Neurostimulation Devices Market, Segmentation By Type Of Stimulation Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Non Invasive Neurostimulation Devices Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Non Invasive Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non Invasive Neurostimulation Devices Market Competitive Landscape And Company Profiles

• 30.1. Non Invasive Neurostimulation Devices Market Competitive Landscape
• 30.2. Non Invasive Neurostimulation Devices Market Company Profiles
  • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Alpha-Stim Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Neurosoft Bioelectronics SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Neuronetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BrainsWay Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Non Invasive Neurostimulation Devices Market Other Major And Innovative Companies

• 31.1. eNeura Inc.
• 31.2. MagVenture A/S
• 31.3. Nexstim Plc
• 31.4. Neuroelectrics Barcelona S.L.U.
• 31.5. Cefaly Technology
• 31.6. ElectroCore Inc.
• 31.7. Brainbox India Private Limited
• 31.8. Flow Neuroscience AB
• 31.9. Fisher Wallace Laboratories Inc.
• 31.10. Sooma Medical
• 31.11. Aleva Neurotherapeutics SA
• 31.12. NeuroSigma Inc.
• 31.13. Mind Alive Inc.
• 31.14. TheBrainDriver LLC
• 31.15. Caputron Medical Products LLC.

32. Global Non Invasive Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non Invasive Neurostimulation Devices Market

34. Recent Developments In The Non Invasive Neurostimulation Devices Market

35. Non Invasive Neurostimulation Devices Market High Potential Countries, Segments and Strategies

• 35.1 Non Invasive Neurostimulation Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Non Invasive Neurostimulation Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Non Invasive Neurostimulation Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer